Propofol and Fentanyl Versus Midazolam and Fentanyl for Endoscopy Sedation in Cirrhotic Patients
NCT ID: NCT00906139
Last Updated: 2009-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
210 participants
INTERVENTIONAL
2008-03-31
2009-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Post Anesthetic Recovery Time in Sedated Patients for Colonoscopy
NCT03813303
Comparison Between Continuous Infusion and Intermittent Bolus Injection of Propofol for Deep Sedation During ERCP
NCT01900938
Randomised Controlled Study of Popofol Versus Midazolam as Sedation in Endoscopy With Advanced Liver Disease.
NCT03063866
Optimization of Sedation Protocol for Endoscopic Procedures Using Impedance Ventilation Monitor.
NCT06060626
Cognitive Impairment Following Sedation for Colonoscopy With Propofol, Midazolam and Fentanyl Combinations
NCT00446420
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Propofol
To receive propofol (0.5 mg/kg up to 400 mg) and fentanyl (0.05 mg);
Propofol
Propofol dose: 0.5 mg/kg up to 400 mg
Fentanyl
Fentanyl dose: 0.05 mg
Midazolam
To receive midazolam (0.1 mg/kg) and fentanyl (0.05 mg).
Midazolam
Midazolam dose: 0.1 mg/kg
Fentanyl
Fentanyl dose: 0.05 mg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Propofol
Propofol dose: 0.5 mg/kg up to 400 mg
Midazolam
Midazolam dose: 0.1 mg/kg
Fentanyl
Fentanyl dose: 0.05 mg
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA II or III
* Child A, B or C
* Age between 18 years and 75 years
* Patients that agree in participate of study and signed the contentment term
Exclusion Criteria
* Recuse
* Hepatocellular carcinoma
* Contraindications to drugs
* ASA IV or V
* Hepatic encephalopathy, neurologic diseases
* Opioids, narcotics, MAO inhibitors or benzodiazepines use
* Alcohol abuse
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of São Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Federal University of São Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federal University of São Paulo
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LCorreia
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.